###### Key messages

-   Lung resection is followed by a systemic innate immune response characterised by an increase in classical and intermediate monocytes, heightened pro-inflammatory responsiveness of monocytes, and reduced neutrophil phagocytic capacity.

-   Within 2 hours of lung resection, an inflammatory response evolves in the contralateral lung.

-   Pre-operative and pre-operative characteristics of the innate cellular innate immune response appear to be associated with post-operative lung inflammation, though these require validation in future studies.

Introduction {#s1}
============

In recent years, there has been increasing recognition of a complex innate immune response to insults such as sepsis or trauma. It is generally accepted that such processes induce not only a systemic inflammatory response syndrome, but also a compensatory anti-inflammatory response (CARS).[@R1] [@R2] The magnitude and duration of both processes appear to dictate clinical outcomes, suggesting that a closely coordinated interaction between these apparently divergent responses is beneficial.[@R3]

These concepts have largely arisen from meticulous serial analysis of plasma cytokines. Far less is known about the innate cellular immune response in this context. Monocytes are known to infiltrate the lung in a diverse range of inflammatory lung conditions.[@R4] Improved methods for phenotypic characterisation have led to clear demonstrations of distinct subsets of circulating murine monocytes, and a similar concept has emerged in humans with the identification of classical, non-classical and intermediate monocyte subsets.[@R8] Monocyte deactivation has been associated with adverse outcomes in patients with sepsis.[@R12] However, remarkably little is known about serial functional responses of monocytes and neutrophils under pathological conditions.

The aim of this study was therefore to perform the first detailed 'within-patient' characterisation of circulating cellular innate responses after lung resection. The setting of lung resection was chosen as there is a relatively consistent and controlled level of surgical trauma, and because thoracic surgery may be complicated by postoperative infection or acute lung injury (ALI).[@R16] Secondary aims were: (1) to make preliminary analyses of whether innate immune dysfunction predicted postoperative complications (in the form of alveolar consolidation on chest X-ray (CXR) at 72 h) and (2) to take the unique opportunity to study serial cellular responses in bronchoalveolar lavage (BAL) fluid from patients having lung resection.

Materials and methods {#s2}
=====================

Recruitment of patients {#s2a}
-----------------------

Patients referred for thoracic surgery with proven or clinically suspected lung cancer were enrolled prospectively. They were excluded if there was evidence of metastatic disease on routine preoperative staging. All patients were surgically staged with bronchoscopy and videomediastinoscopy prior to lung resection. Informed, written consent was obtained from all patients.

Blood sampling and preparation {#s2b}
------------------------------

Venepuncture was performed preoperatively and at 6, 24 and 48 h postoperatively. Isolation of granulocytes and mononuclear cells from whole blood was performed at each time point using dextran sedimentation and percoll gradient extraction.[@R19] Neutrophil purity in extracted granulocyte layers was consistently \>95%. Monocytes were positively selected from the mononuclear layer using magnetic beads labelled with an anti-CD14 antibody (Miltenyi Biotec, Germany). Using this technique, the monocyte purity was consistently \>90%.

### Flow cytometric analysis of monocyte subsets {#s2b1}

Five-colour immunofluorescent labelling of the mononuclear layer of freshly prepared blood was performed (using antibodies specific to HLA-DR, CD14, CD16, CCR2 and CX~3~CR1). An unstained sample and five single stains were used to compensate the data with a mixture sample containing all five antibodies used to identify monocyte subsets.

Monocytes were identified by gating on a cell population with the characteristic forward scatter and side scatter. Within this gate, HLA-DR-positive cells were identified, and relative CD14 and CD16 expression on these was used to identify the three principal human monocyte subsets (CD14++CD16− 'classical' monocytes; CD14++CD16+ 'intermediate' monocytes; and CD14+CD16++ 'non-classical' monocytes). Antibodies to CCR2 and CX~3~CR1 were used to confirm that each of the three monocyte subsets (identified by the relative CD14/CD16 expression) had the characteristic expression profile for these receptors.

Stimulation of monocytes with lipopolysaccharide {#s2c}
------------------------------------------------

Isolated monocytes were stimulated with lipopolysaccharide (LPS) from *Escherichia coli* 026:B6 (Sigma, UK), final concentration 154 ng/mL, for 18 h in duplicate in a 24-well Costar plate (Corning, Amsterdam). Supernatants were collected and frozen at −80°C until later analysis. Data were adjusted for total protein using the Bradford method (Sigma, UK).

Phagocytosis by neutrophils {#s2d}
---------------------------

Phagocytosis by freshly prepared neutrophils was evaluated by flow cytometric analysis of neutrophils exposed to serum-opsonised zymosan (from *Saccharomyces cerevisiae*) preconjugated with Alexa Fluor 594 (Invitrogen, UK). Following culture in suspension for 30 min, addition of trypan blue (to quench extracellular fluorescence) and multiple washes, flow cytometric analysis was performed (BD Special Order LSR Fortessa, Becton Dickinson). The data were subsequently analysed using FlowJo Software (V.7.6.3; TreeStar Inc) with the unstained sample being used as the basis of the gating for positive phagocytosis.

Bronchoalveolar lavage {#s2e}
----------------------

BAL was performed twice in each patient at least 1 week apart, thereby allowing any BAL-induced inflammation to recede. The first BAL was performed prior to mediastinoscopy, that is, before any form of surgical trauma, thus serving as a preoperative sample. The second BAL was performed immediately after lung resection and served as an early postoperative comparator sample. BAL was performed in the lung contralateral to the tumour on both occasions, and a different lobe was lavaged at the second BAL.

BAL was performed under general anaesthesia using a standardised technique.[@R20] Quantification of cell counts, total protein and preparation of cell-free supernatant for later analysis were performed as described previously.[@R20]

Cytokine analysis {#s2f}
-----------------

Serum and BAL cytokines were analysed using a commercially available Cytometric Bead Array kit (BD Human Inflammatory Cytokines Kit, Becton Dickinson Biosciences).

Definition of postoperative pneumonia {#s2g}
-------------------------------------

Pneumonia was predefined as new alveolar infiltrates on a CXR at 72 h, reported by an experienced pulmonary radiologist blinded to study results, plus two from three of: temperature \>38.0°C or \<35.5°C; white cell count \>11.0×10^9^/L or \<4.0×10^9^/L; and positive microbiology on sputum culture.

Statistical analysis {#s2h}
--------------------

Data were analysed using the Minitab 16 Software (Minitab Inc). Normality of distribution was assessed using the Anderson-Darling test. Non-normally distributed data were log~10~ transformed prior to further analysis. Postoperative changes were compared using the paired t test and groups compared using the two-sample Student t test. A repeated measures ANOVA/ANCOVA model was created to incorporate analysis of variance attributable to time points and the pneumonia group. To determine relative risk, Youden\'s test was applied to parameters that were significantly higher in patients with pneumonia to establish the optimal cut-off for predicting pneumonia. The relative risk for each parameter was then determined using Fisher\'s test and the likelihood ratio calculated. Statistical significance was considered to be at the p\<0.05 level. The statistical programme GraphPad Prism 5 (GraphPad Software Inc) was used for this purpose.

Results {#s3}
=======

Patient characteristics {#s3a}
-----------------------

Fifty-three patients consented to take part, of whom 13 were excluded (7 had lymph node involvement at mediastinoscopy, 2 withdrew consent postoperatively, 1 was deemed medically unfit for resection after staging and 3 were excluded for practical reasons precluding full sample collection). Demographic and clinical characteristics of the 40 patients analysed are shown in [table 1](#BMJRESP2014000045TB1){ref-type="table"}. Sixteen patients (40%) had a preoperative diagnosis of chronic obstructive pulmonary disease. Surgical resection was performed whenever possible via video-assisted thoracoscopic surgery (VATS) lobectomy (n=26); otherwise, posterolateral thoracotomy (n=14) was performed. Seventeen patients (42.5%) proved to have adenocarcinoma and 14 (35.0%) had squamous cell carcinoma. Details of final histological diagnoses and staging are described in the online supplementary section (table S1).

###### 

Patient characteristics

  Characteristic                                                                All patients
  ----------------------------------------------------------------------------- ---------------
  Male, n (%)                                                                   23 (57.5)
  Mean age, years (SD)                                                          66.9 (7.8)
  Mean BMI, kg/m^2^ (SD)                                                        26.6 (4.3)
  Current smoker, n (%)\*                                                       13 (32.5)
  FEV~1~, % predicted (SD)                                                      87.3 (23.8)
  FEV~1~/FVC, % predicted (SD)                                                  88.5 (13.9)
  T~CO~, % predicted (SD)                                                       72.0 (21.9)
  K~CO~, % predicted (SD)                                                       78.1 (17.6)
  Mean thoracoscore (SD)                                                        2.5 (1.7)
  Inpatient mortality, n (%)                                                    0 (0)
  Median blood loss, mL (IQR)                                                   120 (55--300)
  Mean change in blood Hb, g/L (between pre-op and day 1 post-op values) (SD)   13.8 (10.0)
  Mean duration of surgery, minutes (SD)                                        203 (44.4)

Thoracoscore is a validated scoring system used to predict outcomes after thoracic surgery.[@R21]

\*Current or ex-smoker \<2 months duration.

BMI, body mass index; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; Hb, haemoglobin; K~co~, diffusing capacity for carbon monoxide, corrected for lung volume; Post-op, postoperative; Pre-op, postoperative; T~co~, diffusing capacity for carbon monoxide.

Response of circulating blood neutrophils and monocytes to lung resection {#s3b}
-------------------------------------------------------------------------

As expected, a significant postoperative leucocytosis was observed (p\<0.0005 by ANOVA modelling). This largely reflected a significant rise in blood neutrophils, but there was an associated significant rise in monocytes and a fall in lymphocytes (p\<0.0005 for each cell type by ANOVA modelling).

[Table 2](#BMJRESP2014000045TB2){ref-type="table"} describes the effect of LPS on blood-derived monocytes. It should be emphasised that these data are for all cytokines released from circulating CD14-positive monocytes (ie, no inferences can be drawn in relation to secretion by monocyte subsets or to intracellular expression of the cytokines described). It should also be emphasised that each time point describes the effects of LPS stimulation---basal levels of cytokine secretion from preoperative monocytes that were not stimulated with LPS are shown in the online supplementary section (table S2). ANOVA modelling revealed a significant postoperative increase in IL-8 and tumour necrosis factor (TNF) release from monocytes stimulated with LPS *ex vivo* ([table 2](#BMJRESP2014000045TB2){ref-type="table"}). By 48 h IL-8, TNF and IL-6 secretion were increased significantly, and IL-10 secretion decreased significantly, suggesting a tendency towards monocytes exhibiting a more proinflammatory state of responsiveness.

###### 

*Ex vivo* monocyte responsiveness to stimulation with LPS

  Cytokine   0 h                 6 h                     24 h                48 h                    ANOVA p Value
  ---------- ------------------- ----------------------- ------------------- ----------------------- ---------------
  IL-8       1334 (915--1923)    2325 (1194--3059)\*\*   2177 (1072--2734)   2409 (1420--2787)\*\*   0.034
  IL-6       282 (130--362)      391 (170--580)          395 (146--601)      454 (192--703)\*        0.358
  TNF        39.2 (25.8--49.6)   40.7 (25.4--69.5)       43.6 (23.8--67.8)   48.1 (34.8--82.4)\*     0.028
  IL-10      2.14 (1.18--3.52)   2.61 (0.88--5.07)       1.96 (1.02--3.36)   1.63 (0.78--2.77)\*     0.122
  IL-1β      28.1 (15.5--52.6)   20.1 (11.6--35.1)       23.4 (11.1--73.5)   18.7 (10.8--32.7)       0.291
  IL-12      0.17 (0.14--0.26)   0.18 (0.12--0.24)       0.19 (0.13--0.26)   0.16 (0.13--0.26)       0.451

Blood monocytes were isolated at each of the four perioperative time points and stimulated with LPS for 18 h, ie, isolated monocytes were stimulated once with LPS---no cells received repeated application of LPS. Cytokine concentrations in supernatants were quantified. Data were adjusted for total protein content. Data are presented as medians and IQR. Data were analysed for trend by ANOVA; individual time points were assessed relative to the preoperative value by paired Student t test, \*p\<0.05, \*\*p\<0.005. n=40 for all time points except 48 h, where n=38.

ANOVA, analysis of variance; LPS, lipopolysaccharide; TNF, tumour necrosis factor.

The response in serum cytokines over the same time course was subtly different from the response of isolated monocytes to LPS. In serum, IL-6, IL-8 and IL-10 showed very similar trends, all rising gradually to 24 h, and returning towards (but not back to) baseline by 48 h (all p\<0.0005 by ANOVA modelling; details are found in the online supplementary section, table S3). No significant differences were observed in the postoperative serum levels of IL-1β, IL-12 or TNF.

Surgery was associated with a significant absolute increase in circulating populations of both classical and intermediate monocytes postoperatively, with a corresponding non-significant trend towards a reduction in the number of non-classical monocytes ([figure 1](#BMJRESP2014000045F1){ref-type="fig"}A, B). The increase in classical and intermediate monocytes appeared to be established by 24 h.

![Postoperative changes in blood monocyte subsets. (A) Serial flow cytometry plots from a single representative patient, illustrating the quantification strategy (as outlined in the Methods section). Mononuclear cells were obtained from whole blood subjected to dextran sedimentation and discontinuous percoll gradients. The monocyte population was identified by gating on characteristic forward scatter and side scatter appearances. Within this gate, HLA-DR expressing cells were identified, and in this population staining for CD14 and CD16 defined 'classical' CD14++CD16− monocytes (Q3, bottom right quadrant), 'intermediate' CD14++CD16+ monocytes (Q2, top right quadrant) and 'non-classical' CD14+CD16++ monocytes (Q1, top left quadrant). As an additional quality control, expression of CCR2 and CX~3~CR1 was assessed, to confirm that the expected expression pattern of these receptors within each monocyte subset was observed. (B) Serial monocyte subset counts in blood. Median values are shown with the IQR in brackets. Paired t tests were used to determine postoperative change, n=39 preoperatively, n=38 at 24 h and n=27 at 48 h.](bmjresp2014000045f01){#BMJRESP2014000045F1}

ANOVA modelling revealed a small but statistically significant postoperative reduction in the phagocytic capacity of neutrophils in suspension (the percentage of neutrophils ingesting 2 or more zymosan particles (expressed as median with IQR in parenthesis) was 84 (73--91) at baseline, 84 (68--90) at 6 h, 79 (64--86) at 24 h, and 79 (63--87) at 48 h; ANOVA for overall trend, p=0.047).

Pulmonary response to lung resection {#s3c}
------------------------------------

Surgery was associated with a significant increase in total leucocyte count, total protein and levels of IL-1β, IL-6, IL-8 and IL-10 in BAL fluid retrieved from the contralateral lung in the immediate postoperative period ([table 3](#BMJRESP2014000045TB3){ref-type="table"}). No evidence of infection was found in any of the BAL fluid cultures at this time point.

###### 

Postoperative changes in BAL fluid

                                       Preoperative BALF    Postoperative BALF   p Value
  ------------------------------------ -------------------- -------------------- ----------
  Total Protein, μg/mL (IQR)           118 (68.0--188)      187 (94.3--264)      0.029
  Leucocyte count, millions/mL (IQR)   0.10 (0.07--0.17)    0.18 (0.09--0.31)    0.012
  Macrophages/monocytes, % (IQR)       93 (75--96)          84 (45--92)          0.232
  Neutrophils, % (IQR)                 4 (2--23.5)          13 (3--49)           0.176
  Lymphocytes, % (IQR)                 2 (1--3)             3 (1--4)             0.259
  Other leucocyte, % (IQR)             \<1 (0)              \<1 (0)              1
  IL-10, pg/mL (IQR)                   0 (0.1--0.99)        0.77 (0--2.07)       0.018
  IL-1β, pg/mL (IQR)                   1.14 (0--7.59)       6.22 (1.50--24.58)   0.002
  IL-6, pg/mL (IQR)                    4.67 (1.08--10.71)   17.71 (4.29--45.7)   \<0.0005
  IL-8, pg/mL (IQR)                    114 (61.6--275)      258 (95.7--733)      0.017

BAL was always performed in the non-operated lung. The preoperative and postoperative BALs were performed in different lung segments. Data are presented as median and IQR, while statistical analysis was by paired Student t test. Total protein and differential leucocyte counts, n=33. Total leucocyte count, n=36. Cytokine analysis, n=35.

BAL, bronchoalveolar lavage; BALF, BAL fluid.

Associations with postoperative pneumonia {#s3d}
-----------------------------------------

Fourteen patients (35%) developed postoperative pneumonia according to the predefined criteria. There was no significant difference in the rate of pneumonia according to which form of surgery was performed (35% in patients undergoing VATS, 36% in patients having thoracotomy). No patients developed ALI/acute respiratory distress syndrome as measured by published criteria.[@R22] The only baseline clinical factor associated with a significant difference between those who did or did not develop pneumonia was the transfer factor for carbon monoxide (60.9% predicted in those who developed pneumonia vs 77.9% predicted in those who did not, p=0.010). Further details of baseline clinical characteristics for these two subgroups are found in the online supplementary section (table S4).

We went on to test whether individual innate immune parameters were associated with the development of postoperative pneumonia ([table 4](#BMJRESP2014000045TB4){ref-type="table"} panel A). In general, serum cytokines were not associated with pneumonia, and where they were, the proportional difference was small. Similarly, neutrophil phagocytosis was not associated with pneumonia. In contrast, preoperative cell counts and elements of monocyte responsiveness appeared to be associated with pneumonia.

###### 

Associations with postoperative pneumonia

  Panel A                                                                                       
  ----------------------------------------------------- ------------------- ------------------- -------
  Preoperative leucocyte count in blood (×10^9^/L)      9.1 (8.4--11.2)     7.9 (6.7--9.5)      0.007
  Preoperative blood neutrophils (×10^9^/L)             5.8 (5.1--6.9)      4.7 (4.1--5.7)      0.015
  Preoperative BAL leucocyte count (millions/mL)        0.14 (0.1--0.2)     0.08 (0.0--0.1)     0.012
  Serum IL-8 (48 h; pg/mL)                              17.4 (13.2--21.1)   14.5 (10.5--16.8)   0.031
  Serum TNF (48 h; pg/mL)                               6.9 (4.0--10.3)     7.5 (5.3--9.2)      0.023
  Monocyte supernatant IL-12 (preoperative; pg/mL/μg)   0.140 (0.1--0.2)    0.187 (0.1--0.3)    0.008
  Monocyte supernatant IL-10 (24 h; pg/mL/μg)           3.2 (2.1--4.7)      1.4 (0.5--2.4)      0.014
  Monocyte supernatant IL-6 (24 h; pg/mL/μg)            525 (347--823)      298 (115--532)      0.040
  Monocyte supernatant IL-6 (48 h; pg/mL/μg)            616 (397--778)      315 (176--607)      0.014
  Monocyte supernatant IL-8 (48 h; pg/mL/μg)            2525 (2127--3448)   2298 (1043--2719)   0.040

  Panel B                                                                                                 
  ---------------------------------------------- ------- -------- ------------------- ------------------- -------------------
  Pre-op blood neutrophils (×10^9^/L)            5.04    0.02     3.3 (1.1 to 10.1)   2.04 (1.17--3.57)   0.32 (0.11--0.99)
  Pre-op BAL white cell count (millions/mL)      0.104   0.0093   3.4 (1.3 to 9.0)    2.55 (1.25--5.19)   0.40 (0.17--0.94)
  Pre-op monocyte supernatant IL-12 (pg/mL/μg)   0.147   0.0168   3.0 (1.2 to 7.3)    2.78 (1.25--6.20)   0.46 (0.22--0.96)
  Monocyte supernatant IL-10 (24 h; pg/mL/μg)    1.988   0.0072   4.1 (1.3 to 12.3)   2.55 (1.35--4.83)   0.31 (0.11--0.87)
  Monocyte supernatant IL-6 (24 h; pg/mL/μg)     414     0.02     3.1 (1.2 to 8.1)    2.32 (1.19--4.51)   0.41 (0.17--0.98)

\(A\) Factors associated with postoperative pneumonia. Data are presented as medians with IQR in brackets. Statistical analysis was performed using an unpaired Student t test. Only factors that were significantly different in the two groups are shown. n=40 for all comparisons except preoperative BAL, serum and monocyte supernatant experiments at 48 h, where n=38.

\(B\) Predictive strength of biomarkers associated with pneumonia. The optimum cut point to dichotomise each parameter was determined by Youden\'s index. n=40 for all comparisons except preoperative BAL where n=38.

For both (A) and (B), monocyte supernatant values refer to monocytes stimulated *ex vivo* with LPS.

BAL, Bronchoalveolar lavage; LPS, lipopolysaccharide; LR, likelihood ratio; Pre-op, preoperative; RR, relative risk; TNF, tumour necrosis factor.

To test this further, parameters identified in [table 4](#BMJRESP2014000045TB4){ref-type="table"} panel A were used to establish which had a significant relative risk for pneumonia ([table 4](#BMJRESP2014000045TB4){ref-type="table"} panel B). In this setting, relatively higher neutrophils in blood and leucocytes in BAL appeared to be associated with pneumonia. Interestingly, relatively higher anti-inflammatory responses in LPS-stimulated monocytes (IL-12 preoperatively and IL-10 at 24 h) were associated with pneumonia, with IL-6 being the only proinflammatory cytokine to show an association.

Discussion {#s4}
==========

While several studies have assessed the serum cytokine response after thoracic surgery,[@R23] our findings provide a first detailed, serial characterisation of monocyte and neutrophil function after lung resection. Elective surgery provided a particularly useful setting in which to study innate immune characteristics in the lung and blood, given the opportunity to obtain a preoperative baseline. Our data suggest that classical monocytes are mainly responsible for postoperative monocytosis. Intermediate monocytes were also significantly increased, but interestingly non-classical monocytes appeared to be numerically and proportionally decreased relative to baseline, at least as far out as 48 h. Similar numerical changes have been described after stroke.[@R26] The fate of intermediate monocytes in this setting remains to be determined---some evidence exists for this population having inherent plasticity, with the capacity to become classical or non-classical monocytes depending on their environment.[@R27] [@R28]

We also report a dynamic state of monocyte responsiveness to LPS, with IL-8 secretion increased within 6 h, and a general tendency for a more proinflammatory cytokine responsiveness to LPS at 48 h. The pattern of increased LPS-induced IL-8 secretion from monocytes postoperatively is broadly similar to that described in a smaller study of mononuclear cells from (non-thoracic) surgical patients, though we did not observe the increase in IL-1β described in that study.[@R29] Certainly, our data suggest that, on average, monocytes have a heightened proinflammatory response to LPS in the postoperative period.

In this regard, a number of points are worth making. First, our data suggest that the monocyte response generates proinflammatory cytokines from an early stage. This is broadly reminiscent of the pattern described in serum. Second, it is intriguing that the relative risk for pneumonia was most closely associated with monocyte release of the anti-inflammatory cytokine IL-10 ([table 4](#BMJRESP2014000045TB4){ref-type="table"} panel B). With regard to associations with postoperative pneumonia, ours was very much a pilot, hypothesis-generating study, and as such the sample size was too small (and not designed) to draw conclusions on whether a relative anti-inflammatory postoperative monocyte response is predictive of subsequent pneumonia. Nevertheless, IL-10 is differentially expressed by monocyte subsets,[@R30] and has been implicated in driving monocyte deactivation,[@R31] which in turn is associated with increased risk of infection.[@R12]

Our data also suggested that higher preoperative total cell counts in BAL (predominantly macrophages) and higher levels of circulating neutrophils are associated with a higher risk of postoperative pneumonia. None of our patients had infection detected in BAL samples preoperatively. It is tempting to speculate that patients with a relatively heightened systemic and pulmonary innate immunity in the preoperative phase are more susceptible to the 'second hit' of surgery, and/or to low-level postoperative infective inocula, especially if their monocytes tend to yield a relatively anti-inflammatory profile to inflammatory stimuli. Interestingly, our data did not suggest that neutrophil phagocytosis contributed to risk of infection. While the change in neutrophil phagocytosis postoperatively was statistically significant, and consistent with observations after abdominal surgery,[@R32] the levels of phagocytosis reported here are well within the normal range. This is in striking contrast to the situation in critically ill cohorts of patients, where reduced neutrophil phagocytosis (\<50% of neutrophils ingesting 2 or more zymosan particles) is independently associated with increased risk of nosocomial infection.[@R33]

A unique opportunity to study early innate responses in the lung was also afforded by this study. Previous studies have described pulmonary inflammation after thoracic surgery using serial BAL.[@R34] However, they have generally been confounded by short intervals between sampling, and by relatively small volumes of instillate. The present study overcame these limitations. Our results confirm that the lung *contralateral* to the operated tumour is inflamed extremely early in the course of thoracic surgery (ie, within the first couple of hours), with increased neutrophil influx and protein leak across the alveolar-capillary membrane. This effect may be partly attributable to one lung ventilation, which has been shown to induce inflammatory effects in the lung.[@R35] One-lung ventilation was used in all patients in this study. Interestingly, only the preoperative BAL cell count appeared to predict postoperative pneumonia ([table 4](#BMJRESP2014000045TB4){ref-type="table"} panel B), and it remains to be determined whether the postoperative inflammatory response in the lung is exaggerated in patients who have a high preoperative cell count in BAL fluid.

We should emphasise again that our analysis of factors associated with postoperative pneumonia in this population was exploratory and hypothesis generating. As described above, the apparent association with the IL-10 release from monocytes is intriguing, but it must be emphasised that this is an isolated finding. There was not a frank CARS response in these patients. The inevitable conclusions are, first, that the contribution of, and dynamic interplay between, proinflammatory and anti-inflammatory cascades are likely to contribute to the pulmonary inflammation observed, and second, that our findings require validation in larger and multicentre cohorts. However, we believe they represent an important first step in this regard, and add to the list of factors potentially associated with complications after thoracic surgery, such as low diffusing capacity for carbon monoxide, certain gene polymorphisms and inflammatory parameters.[@R37] Ultimately, this work was based on the expectation that a greater understanding of the innate immune processes associated with postoperative complications may allow stratified approaches to management (based on the expectation of postoperative risk) and/or the evolution of novel strategies for the prevention of complications through manipulation of the innate immune response.

When considering our data on postoperative risk, it must be kept in mind that our definition of 'pneumonia' is in the strict sense of 'alveolar inflammation', and the radiological consolidation could represent infiltration of inflammatory cells without infection. We did not judge it ethical to request a further routine BAL for microbiological culture in recovering surgical patients. Nevertheless, our criteria for pneumonia were predefined, alveolar shadowing on CXR was judged by an experienced thoracic radiologist, and 8 of the 14 patients with 'pneumonia' did have bacterial pathogens isolated from the sputum as part of their routine clinical care. Therefore, while we cannot be certain that all patients with 'pneumonia' had bacterial infection, we can be confident that they had alveolar inflammation. It is also important to emphasise that all patients with pneumonia made a good recovery.

In addition, a number of potential limitations should be considered when interpreting our data. Our sample size was small, as we deliberately concentrated on what we believe to be by far the most comprehensive and detailed serial analysis within individual patients in this setting. Our findings provide initial insights but require confirmation in larger cohorts. Also, most of our patients had lung cancer, a burden of tobacco exposure and variable medications including statins, all of which may potentially influence innate immunity. Nevertheless, these factors are likely to be characteristic of, and relatively consistent in, populations of patients being worked up for lung cancer resection, and so the data remain relevant in that specific context. Furthermore, as with all functional studies using neutrophils and monocytes, we cannot be certain that the *ex vivo* monocyte responsiveness data are representative of biological activity *in vivo*. In addition, our protocol did not mandate a standardised anaesthetic approach in all patients (anaesthesia was entirely at the discretion of the anaesthetic team). While we are unaware of any significant variations in anaesthetic practice, potential variations could theoretically impact particularly on our BAL data.

In summary, thoracic surgery mobilises circulating classical and intermediate monocytes, and is associated with the release of proinflammatory cytokines from blood monocytes in response to inflammatory stimuli. Monocyte responsiveness to LPS and preoperative levels of leucocytosis appears to be associated with a risk of postoperative pneumonia, but this requires further characterisation and confirmation in larger cohorts.
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